These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36257581)

  • 1. Prevalence and causes of pre-donation deferrals among potential plateletpheresis donors at a blood center in Eastern China.
    Zhu H; Wang J; Lin H
    Transfus Clin Biol; 2023 May; 30(2):189-194. PubMed ID: 36257581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plateletpheresis donor deferral patterns at a tertiary care hospital in North India: A need for rethink of haemoglobin cutoff.
    Sharma H; Khajuria K; Bansal N; Thakur K; Sharma A
    Transfus Clin Biol; 2023 May; 30(2):268-271. PubMed ID: 36893913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and causes of pre-donation deferrals at a Chinese blood center.
    Yang Y
    Transfus Apher Sci; 2021 Aug; 60(4):103153. PubMed ID: 34016553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of applying the 2day deferral for repeat plateletpheresis: Indian perspective.
    Nomani L; Raina TR; Sidhu M
    Transfus Apher Sci; 2013 Jun; 48(3):341-3. PubMed ID: 23643473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor deferral characteristics for plateletpheresis at a tertiary care center in India- a retrospective analysis.
    Pujani M; Jyotsna PL; Bahadur S; Pahuja S; Pathak C; Jain M
    J Clin Diagn Res; 2014 Jul; 8(7):FC01-3. PubMed ID: 25177566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of low haematocrit among repeat donors in São Paulo, Brazil: eleven year longitudinal analysis.
    Almeida FN; Sabino EC; Tunes G; Schreiber GB; da Silva PP; Carneiro-Proietti AB; Ferreira JE; Mendrone A
    Transfus Apher Sci; 2013 Dec; 49(3):553-9. PubMed ID: 24128819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of blood donor pre-donation deferral in Dubai: characteristics and reasons.
    Al Shaer L; Sharma R; AbdulRahman M
    J Blood Med; 2017; 8():55-60. PubMed ID: 28579846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained decreases in platelet count associated with multiple, regular plateletpheresis donations.
    Lazarus EF; Browning J; Norman J; Oblitas J; Leitman SF
    Transfusion; 2001 Jun; 41(6):756-61. PubMed ID: 11399815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plateletpheresis donation through donor awareness, motivation, and recruitment drives: A unique concept and experience from a tertiary care oncology centre in India.
    Ojha S; Gupta AM; Nagaraju P; Poojary M; Ravatale A
    Transfus Clin Biol; 2022 Feb; 29(1):65-69. PubMed ID: 34302952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of temporary deferrals on future blood donation behavior across the donor life cycle.
    Clement M; Shehu E; Chandler T
    Transfusion; 2021 Jun; 61(6):1799-1808. PubMed ID: 33780022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Retrospective Analysis of Apheresis Donor Deferral and Adverse Reactions at a Tertiary Care Centre in India.
    Arora D; Garg K; Kaushik A; Sharma R; Rawat DS; Mandal AK
    J Clin Diagn Res; 2016 Nov; 10(11):EC22-EC24. PubMed ID: 28050376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre- and post- donation haematological values in healthy donors undergoing plateletpheresis with five different systems.
    Das SS; Chaudhary R; Verma SK; Ojha S; Khetan D
    Blood Transfus; 2009 Jul; 7(3):188-92. PubMed ID: 19657482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 3-year analysis of plateletpheresis donor deferral pattern in a tertiary health care institute: assessing the current donor selection criteria in Indian scenario.
    Tondon R; Pandey P; Chaudhry R
    J Clin Apher; 2008; 23(4):123-8. PubMed ID: 18615635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plateletpheresis donor deferral pattern: A retrospective 4-year data analysis at tertiary care center in India.
    Yadav BK; Shrivastava H; Katharia R; Chaudhary RK
    Asian J Transfus Sci; 2022; 16(2):214-218. PubMed ID: 36687534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor deferral and resulting donor loss at the American Red Cross Blood Services, 2001 through 2006.
    Zou S; Musavi F; Notari EP; Rios JA; Trouern-Trend J; Fang CT
    Transfusion; 2008 Dec; 48(12):2531-9. PubMed ID: 18717777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of blood donor deferral in Japan: characteristics and reasons.
    Ngoma AM; Goto A; Sawamura Y; Nollet KE; Ohto H; Yasumura S
    Transfus Apher Sci; 2013 Dec; 49(3):655-60. PubMed ID: 23891317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood donors deferral prevalence and causes in a tertiary health care hospital, southern Nigeria.
    Okoroiwu HU; Asemota EA
    BMC Health Serv Res; 2019 Jul; 19(1):510. PubMed ID: 31331326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of pre- and post-donation haematological values in plateletpheresis donors.
    Love E; Pendry K; Hunt L
    Vox Sang; 1993; 65(3):209-11. PubMed ID: 8249363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and causes of blood donor deferrals among clients presenting for blood donation in northern Tanzania.
    Valerian DM; Mauka WI; Kajeguka DC; Mgabo M; Juma A; Baliyima L; Sigalla GN
    PLoS One; 2018; 13(10):e0206487. PubMed ID: 30359434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pre-donation deferrals--a teaching hospital experience.
    Rabeya Y; Rapiaah M; Rosline H; Ahmed SA; Zaidah WA; Roshan TM
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):571-4. PubMed ID: 18564700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.